Rep. Julie Johnson Sells CME Group Inc. (NASDAQ:CME) Stock

Posted by Grant Hamersma on Jan 18th, 2026

Representative Julie Johnson (D-Texas) recently sold shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in CME Group stock on December 18th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

Sold $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 12/18/2025.
Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 12/18/2025.
Sold $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 12/18/2025.
Sold $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 12/18/2025.
Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 12/18/2025.
Sold $1,001 – $15,000 in shares of Philip Morris International (NYSE:PM) on 12/18/2025.
Sold $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 12/18/2025.
Sold $1,001 – $15,000 in shares of Bank of America (NYSE:BAC) on 12/18/2025.
Sold $1,001 – $15,000 in shares of Walmart (NASDAQ:WMT) on 12/18/2025.
Sold $1,001 – $15,000 in shares of Republic Services (NYSE:RSG) on 12/18/2025.

CME Group Stock Up 2.5%

NASDAQ:CME traded up $6.85 during mid-day trading on Friday, hitting $279.44. The company had a trading volume of 2,410,026 shares, compared to its average volume of 1,609,797. The business has a fifty day simple moving average of $274.20 and a 200-day simple moving average of $271.79. The firm has a market capitalization of $100.77 billion, a price-to-earnings ratio of 27.08, a PEG ratio of 3.15 and a beta of 0.27. CME Group Inc. has a 1 year low of $230.19 and a 1 year high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company’s revenue was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.68 earnings per share. Equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 12th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date was Friday, December 12th. CME Group’s dividend payout ratio is currently 48.45%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. UBS Group restated a “neutral” rating on shares of CME Group in a report on Tuesday, January 6th. Jefferies Financial Group decreased their target price on shares of CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research note on Monday, January 12th. Barclays raised their price target on shares of CME Group from $280.00 to $304.00 and gave the company an “equal weight” rating in a report on Friday, December 12th. Cowen upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, Bank of America raised their target price on CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Ten research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $291.82.

View Our Latest Research Report on CME

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME plans to add Cardano (ADA), Chainlink (LINK) and Stellar (XLM) futures — standard and micro contracts — boosting crypto product breadth and capital‑efficient tools for clients; listing targeted for Feb. 9 pending review, which could lift futures trading volumes and fee revenue. CME Group Expands Crypto Futures With Cardano, Chainlink, and Stellar
Positive Sentiment: TD Cowen upgraded CME to “Buy”, signaling constructive analyst sentiment that supports upside and likely helped investor confidence. TD Cowen Upgrades CME Group (NASDAQ:CME) to “Buy”
Positive Sentiment: CME is introducing a new, smaller silver futures contract to capture surging retail interest in silver — a product move that can broaden participation and boost notional volumes in metals. Silver Gets a Major Upgrade: CME to Launch New Futures as Retail Demand Hits Record Levels
Neutral Sentiment: Jefferies trimmed its price target slightly (from $304 to $302) but kept a “Buy” rating — modestly lowering upside but still supportive. Jefferies Adjusts Price Target on CME Group
Neutral Sentiment: Morgan Stanley cut its price target by $1 to $319 while retaining an “Overweight” rating — a slight tweak that keeps a bullish stance but marginally lowers modeled upside. Morgan Stanley Lowers CME Price Target
Neutral Sentiment: Analyst previews and coverage notes (e.g., “Here’s What to Expect From CME Group’s Next Earnings Report”) keep focus on volumes/fee trends and macro volatility — useful context but not immediate catalysts. Here’s What to Expect From CME Group’s Next Earnings Report
Negative Sentiment: Goldman Sachs nudged its target slightly lower (from $265 to $264) and maintains a “Sell” rating — a visible negative outlier that can weigh on sentiment among more cautious investors. Goldman Sachs Adjusts CME Group Price Target

Institutional Investors Weigh In On CME Group

A number of institutional investors have recently modified their holdings of CME. Caldwell Trust Co increased its holdings in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after buying an additional 50 shares during the last quarter. Highline Wealth Partners LLC grew its position in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in shares of CME Group in the 3rd quarter valued at approximately $27,000. FNY Investment Advisers LLC bought a new stake in shares of CME Group in the 4th quarter valued at approximately $27,000. Finally, Financial Consulate Inc. acquired a new stake in shares of CME Group during the 3rd quarter valued at approximately $28,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insiders Place Their Bets

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of CME Group stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the transaction, the director directly owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. The trade was a 47.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director William R. Shepard acquired 251 shares of the company’s stock in a transaction that occurred on Tuesday, December 30th. The shares were acquired at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the purchase, the director owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is currently owned by corporate insiders.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

CME Group Company Profile

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.